4th Edition of
International Ophthalmology Conference
March 23-25, 2026 | Singapore
Nanotechnology in Ophthalmology
Nanotechnology is a new concept that will soon become the pinnacle of science and technology. It penetrates using nanometer-sized molecules and has demonstrated its worth in space, medicine, and other fields of science. Because the eye is a small organ that can be easily accessed due to its exposed location, it is an ideal target for nanotechnology. It appears that the "discovery of nanomedicines has reawakened huge aspirations for ophthalmic pharmacotherapy, in which nanostructured drugs are predicted to pass through the eye's limiting barriers." Safe manufacturing procedures and unforeseen biological repercussions of nanomaterial use remain barriers to nanotechnology adoption. These challenges are not insurmountable, and this developing sector is likely to yield innovative treatments for ocular disorders.
- Nanomedicine
- Nano Pharmaceuticals
- Nanostructured Drugs
Shadrokh Nabili
University Hospitals of Morecambe Bay NHS Foundation Trust, United Kingdom
Anna Maria Bassi
University of Genoa, Italy
Tim Jackson
King’s College London, United Kingdom
Pio Conti
University of Chieti, Italy
Gowhar Ahmad
Florence Hospital Srinagar, India
Agnieszka Rosa
Orticus Center for the Treatment of Strabismus and Vision Disorders, Poland
Arrane Selvamogan
Leicestershire Partnership NHS Trust, United KingdomSubmit your abstract Today
Title : Rare and interesting case of Goldenhar’s syndrome in a 3 years old male child
Gowhar Ahmad, Florence Hospital Srinagar, India
Title : Management of common vitreoretinal lesions: An overview and update
Tim Jackson, King’s College London, United Kingdom
Title : Targeting immunological pathways in Behcet's uveitis
Hashim Butt, Bolton Royal Hospital, United Kingdom
Title : Lumevoq gene therapy in leber hereditary optic neuropathy
Magali Taiel, GenSight Biologics, France
Title : The effect of low hypermetropia correction and office-based orthoptic training on binocular vision parameters in children with convergence insufficiency
Agnieszka Rosa, Orticus Center for the Treatment of Strabismus and Vision Disorders, Poland
Title : Evaluating the quality and readability of AI chatbot responses to frequently asked questions on basal cell carcinoma: Implications for patient education and digital health communication
Arrane Selvamogan, Leicestershire Partnership NHS Trust, United Kingdom